Sildenafil Dosing, Efficacy, and Safety in Erectile Dysfunction

Recommended Dosing

Initiate therapy with a 50 mg tablet taken about 1 hour before anticipated sexual activity; adjust to 100 mg for greater efficacy or reduce to 25 mg if tolerability is an issue【1】.
The medication should be used no more than once daily, with the dose taken 0.5–4 hours before activity to align with peak plasma concentrations【1】.

In randomized controlled trials, successful intercourse occurred in ≈ 69 % of attempts with sildenafil versus ≈ 35 % with placebo【2】【3】.
Improved erections were reported by 73–88 % of men receiving sildenafil compared with 26–32 % on placebo【2】【3】.
Benefit was consistent across diverse etiologies, including diabetes, depression, cardiovascular disease, post‑prostatectomy status, multiple sclerosis, renal failure, and liver failure【2】【3】.
A modest dose‑response was observed: 100 mg provided slightly greater improvement than 50 mg【1】【2】.

Prior to initiating sildenafil, a cardiovascular work‑up should estimate the risk of morbidity or mortality associated with sexual activity【4】.
Co‑administration with the calcium‑channel blocker amlodipine produced an average reduction of 8 mm Hg systolic and 7 mm Hg diastolic blood pressure, warranting monitoring【4】.
When combined with antihypertensive agents, clinicians should watch for additive blood‑pressure‑lowering effects【4】.
Concomitant use of alpha‑blockers requires caution due to the potential for orthostatic hypotension【4】.

Verify that patients are using the medication correctly (taken ~1 hour before activity, with adequate sexual stimulation) before labeling therapy as ineffective【4】.
Patient education on proper dosing and the necessity of sexual arousal can restore therapeutic benefit【4】.
In hypogonadal individuals, consider evaluating morning total testosterone and, if low, adding testosterone therapy【4】.
Switching to a different PDE5 inhibitor shows limited evidence of additional benefit【4】.
For complex cases, combination approaches (e.g., antioxidants, low‑intensity shockwave therapy, vacuum erection devices, topical alprostadil) may be contemplated【4】.

The overall incidence of adverse events (headache, flushing, dyspepsia, nasal congestion, visual disturbances, dizziness) is mild to moderate, transient, and does not differ significantly from other PDE5 inhibitors; higher doses do not markedly increase adverse‑event rates【1】.

In adult men with erectile dysfunction, sildenafil achieved successful sexual intercourse in 69 % of attempts (range 52‑85 %) compared with 35.5 % with placebo (high‑quality evidence) 5.
Erectile function improved in 73‑88 % of men receiving sildenafil versus 26‑32 % with placebo (high‑quality evidence) 6.
Efficacy was demonstrated regardless of underlying etiology, including diabetes, depression, cardiovascular disease, post‑prostatectomy status, multiple sclerosis, renal failure, and liver failure (high‑quality evidence) 6.

Dose titration to 100 mg or reduction to 25 mg based on individual efficacy and tolerability is appropriate (clinical guideline) 7.

Absolute contraindication: concurrent use of any nitrate therapy because of the risk of severe, potentially fatal hypotension, myocardial infarction, syncope, or death (clinical guideline) 8.
High‑risk cardiovascular conditions in which sildenafil should not be prescribed include:

After sildenafil administration, nitrates must be avoided for at least 24 hours (clinical guideline) 9.

Co‑administration of sildenafil with amlodipine produces an average reduction of 8 mmHg systolic and 7 mmHg diastolic blood pressure (clinical guideline) 8.